News Announcement

Caplin Point Laboratories: Announcement under Regulation 30 (LODR)-Press Release / Media Release

12-Jun-2023 Download PDF Caplin Point Lab

Press Release regarding grant of United States Food and Drug Administration (USFDA) approval for the Abbreviated New Drug Application (ANDA) Cisatracurium Besylate Injection USP for our subsdiary Caplin Steriles Limited